These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19556761)

  • 21. Ultrafiltration and endotoxin removal from dialysis fluids.
    Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
    Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrapure dialysate for home hemodialysis?
    Ouseph R; Ward RA
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):256-62. PubMed ID: 17603979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endotoxin and bacterial level of dialysate fluid quality.
    Isakozawa Y; Takesawa S; David V
    Contrib Nephrol; 2011; 173():70-75. PubMed ID: 21865778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorption of bacterial endotoxin and retention of bacteria by positively charged membrane filters.
    van Doorne H
    J Parenter Sci Technol; 1993; 47(5):192-8. PubMed ID: 8263658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the DialGuard device for endotoxin removal in hemodialysis.
    Szathmary S; Hegyi E; Amoureux MC; Rajapakse N; Chicorka L; Szalai G; Reszegi K; Derbyshire Z; Paluh J; Dodson B; Grandics P
    Blood Purif; 2004; 22(5):409-15. PubMed ID: 15316195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contamination of dialysis water and dialysate. A survey of 30 centers.
    Bambauer R; Schauer M; Jung WK; Daum V; Vienken J
    ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Filtration fluid for hemodialysis treatment.
    Ikonomov V; Haase G; Stefanidis I; Melzer H; Mann H
    Int J Artif Organs; 2002 May; 25(5):379-85. PubMed ID: 12074334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membranes for endotoxin removal from dialysate: considerations on feasibility of commercial ceramic membranes.
    Bender H; Pfläzel A; Saunders N; Czermak P; Catapano G; Vienken J
    Artif Organs; 2000 Oct; 24(10):826-9. PubMed ID: 11091173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of dialysis fluid: historical background and perspective.
    Ledebo I
    Blood Purif; 2009; 27 Suppl 1():17-9. PubMed ID: 19556758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review: Clinical usefulness of ultrapure dialysate--recent evidence and perspectives.
    Masakane I
    Ther Apher Dial; 2006 Aug; 10(4):348-54. PubMed ID: 16911188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of central concentrate delivery system for hemodialysis in Korea.
    Han SW; Yi JH; Kim HJ
    Blood Purif; 2009; 27 Suppl 1():70-3. PubMed ID: 19556767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The removal efficiency of beta 2-microglobulin, alpha 1-microglobulin and alpha 1-acid glycoprotein by using dialyzers in the bloodstream and transference of endotoxin through membranes].
    Ueyama S; Kiyomizu S; Endo K; Nagayama N; Oda K; Ohashi T; Yamashita W; Harada R; Arima T
    Fukuoka Igaku Zasshi; 1990 Nov; 81(11):355-8. PubMed ID: 1703122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of regular dialysis treatment in Japan (as of 31 December 2007).
    Nakai S; Masakane I; Shigematsu T; Hamano T; Yamagata K; Watanabe Y; Itami N; Ogata S; Kimata N; Shinoda T; Syouji T; Suzuki K; Taniguchi M; Tsuchida K; Nakamoto H; Nishi S; Nishi H; Hashimoto S; Hasegawa T; Hanafusa N; Fujii N; Marubayashi S; Morita O; Wakai K; Wada A; Iseki K; Tsubakihara Y
    Ther Apher Dial; 2009 Dec; 13(6):457-504. PubMed ID: 19954472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of endotoxins in high-flux dialysis.
    Smollich BP; Falkenhagen D; Schneidewind J; Mitzner S; Klinkmann H
    Nephrol Dial Transplant; 1991; 6 Suppl 3():83-5. PubMed ID: 1775273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No evidence for endotoxin transfer across high flux polysulfone membranes.
    Bommer J; Becker KP; Urbaschek R; Ritz E; Urbaschek B
    Clin Nephrol; 1987 Jun; 27(6):278-82. PubMed ID: 3608251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxin rejection by ultrafiltration through high-flux, hollow fiber filters.
    Yamamoto C; Kim ST
    J Biomed Mater Res; 1996 Nov; 32(3):467-71. PubMed ID: 8897153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In search of sterile, endotoxin-free dialysate.
    Gault MH; Duffett AL; Murphy JF; Purchase LH
    ASAIO J; 1992; 38(3):M431-5. PubMed ID: 1457896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the bacteriologicalcontamination of a water treatment line used for haemodialysis and its disinfection.
    Morin P
    J Hosp Infect; 2000 Jul; 45(3):218-24. PubMed ID: 10896801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of regular dialysis treatment in Japan as of 31 December 2006.
    Nakai S; Masakane I; Akiba T; Shigematsu T; Yamagata K; Watanabe Y; Iseki K; Itami N; Shinoda T; Morozumi K; Shoji T; Marubayashi S; Morita O; Kimata N; Shoji T; Suzuki K; Tsuchida K; Nakamoto H; Hamano T; Yamashita A; Wakai K; Wada A; Tsubakihara Y
    Ther Apher Dial; 2008 Dec; 12(6):428-56. PubMed ID: 19140842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endotoxin level measurement in hemodialysis biofilm using "the whole blood assay".
    Marion-Ferey K; Leid JG; Bouvier G; Pasmore M; Husson G; Vilagines R
    Artif Organs; 2005 Jun; 29(6):475-81. PubMed ID: 15926985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.